Reply to ‘Before Reducing Seattle Biopsies, Quantify Their Incremental Dysplasia Yield’
United European Gastroenterology Journal · 2026-11 · 14 (9)
DOI: 10.1002/ueg2.70319 ↗Kurz gefasst
Leserbrief in der Zeitschrift United European Gastroenterology Journal, online erschienen am 02.11.2026. Verfasst von Champika Gamakaranage und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
- County Durham and Darlington NHS Foundation Trust, Darlington, UK.
- Teesside University, Middlesbrough, UK.
- Northern Care Alliance NHS Foundation Trust, Salford, UK.
ORCID-Profile: Champika Gamakaranage, Anjan Dhar, Yeng Ang
Zitieren
APA
Gamakaranage, C., Dhar, A., & Ang, Y. (2026). Reply to ‘Before Reducing Seattle Biopsies, Quantify Their Incremental Dysplasia Yield’. United European Gastroenterology Journal, 14(9). https://doi.org/10.1002/ueg2.70319
Vancouver
Gamakaranage C, Dhar A, Ang Y. Reply to ‘Before Reducing Seattle Biopsies, Quantify Their Incremental Dysplasia Yield’. United European Gastroenterology Journal. 2026;14(9). doi:10.1002/ueg2.70319
BibTeX
@article{Gamakaranage2026,
author = {Gamakaranage, Champika and Dhar, Anjan and Ang, Yeng},
title = {Reply to ‘Before Reducing Seattle Biopsies, Quantify Their Incremental Dysplasia Yield’},
journal = {United European Gastroenterology Journal},
year = {2026},
volume = {14},
number = {9},
doi = {10.1002/ueg2.70319}
}
EUVIMED